Yahoo
OTC Markets OTCPK - Delayed Quote USD

Resonate Blends, Inc. (KOAN)

0.0004 +0.0000 (+16.67%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for KOAN
  • Previous Close 0.0003
  • Open 0.0003
  • Bid 0.0003 x 1826034400
  • Ask 0.0004 x 2641532700
  • Day's Range 0.0003 - 0.0003
  • 52 Week Range 0.0002 - 0.0125
  • Volume 1,800,000
  • Avg. Volume 4,284,545
  • Market Cap (intraday) 121,209
  • Beta (5Y Monthly) 3.70
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Apr 10, 1996
  • 1y Target Est --

Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.

www.apollobiowellness.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

KOAN
88.60%
S&P 500 (^GSPC)
10.73%

1-Year Return

KOAN
94.07%
S&P 500 (^GSPC)
11.11%

3-Year Return

KOAN
99.13%
S&P 500 (^GSPC)
81.91%

5-Year Return

KOAN
99.91%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    51.23%

  • Return on Assets (ttm)

    -28.22%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.23M

  • Net Income Avi to Common (ttm)

    1.14M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.12k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.66M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: